Eric B Dammer Selected Research

Detergents (Detergent)

1/2021	Targeted Quantification of Detergent-Insoluble RNA-Binding Proteins in Human Brain Reveals Stage and Disease Specific Co-aggregation in Alzheimer's Disease.
1/2018	Characterization of Detergent Insoluble Proteome in Chronic Traumatic Encephalopathy.
12/2016	Changes in the detergent-insoluble brain proteome linked to amyloid and tau in Alzheimer's Disease progression.
5/2012	Quantitative analysis of the detergent-insoluble brain proteome in frontotemporal lobar degeneration using SILAC internal standards.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eric B Dammer Research Topics

Disease

39	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 03/2011
16	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 01/2011
9	Cognitive Dysfunction 01/2022 - 12/2016
7	Inflammation (Inflammations) 01/2022 - 01/2017
6	Neuroinflammatory Diseases 06/2021 - 01/2017
6	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2021 - 04/2010
5	Parkinson Disease (Parkinson's Disease) 01/2021 - 10/2013
4	Tauopathies 01/2021 - 01/2020
3	Neoplasms (Cancer) 01/2022 - 01/2019
3	Frontotemporal Dementia (Semantic Dementia) 01/2021 - 01/2018
3	Dementia (Dementias) 01/2020 - 08/2015
3	Disease Progression 01/2020 - 01/2020
2	Chronic Traumatic Encephalopathy 01/2021 - 01/2018
2	Synucleinopathies 12/2020 - 01/2020
2	Hypoxia (Hypoxemia) 01/2017 - 07/2012
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 08/2012 - 04/2010
2	TDP-43 Proteinopathies 01/2012 - 04/2010
1	Multiple Myeloma 04/2022
1	Colorectal Neoplasms (Colorectal Cancer) 01/2022
1	Neuronal Ceroid-Lipofuscinoses (Neuronal Ceroid Lipofuscinosis) 01/2022
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2021
1	Craniocerebral Trauma (Head Injury) 01/2021
1	Intracranial Arteriosclerosis (Cerebral Atherosclerosis) 01/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2019
1	Carcinogenesis 01/2019
1	Lung Neoplasms (Lung Cancer) 01/2019
1	Brain Injuries (Brain Injury) 01/2017
1	Ischemia 01/2017
1	Late Onset Disorders 01/2017
1	Brain Hypoxia-Ischemia (Hypoxia Ischemia, Brain) 01/2017
1	Oculopharyngeal Muscular Dystrophy 01/2017
1	Sleep Wake Disorders 08/2015

Drug/Important Bio-Agent (IBA)

32	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2010
13	ProteomeIBA 12/2021 - 04/2012
8	RNA (Ribonucleic Acid)IBA 01/2022 - 05/2012
7	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2013
6	Amyloid (Amyloid Fibrils)IBA 01/2020 - 10/2013
6	DNA-Binding Proteins (DNA Binding Protein)IBA 08/2012 - 04/2010
5	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2021 - 01/2012
4	Detergents (Detergent)IBA 01/2021 - 05/2012
4	UbiquitinIBA 10/2018 - 04/2010
3	Peptides (Polypeptides)IBA 01/2022 - 05/2012
3	Protein AggregatesIBA 10/2018 - 10/2013
3	U1 Small Nuclear RibonucleoproteinIBA 01/2018 - 10/2013
2	Apolipoproteins E (ApoE)IBA 01/2022 - 01/2018
2	Pharmaceutical PreparationsIBA 01/2022 - 01/2018
2	LipidsIBA 01/2022 - 01/2021
2	Amyloid beta-PeptidesIBA 01/2021 - 12/2016
2	Potassium Channels (Potassium Channel)IBA 01/2021 - 01/2017
2	Phosphotransferases (Kinase)IBA 01/2021 - 01/2015
2	Biological ProductsIBA 01/2020 - 01/2019
2	MicroRNAs (MicroRNA)IBA 10/2016 - 01/2016
2	Glucose (Dextrose)FDA LinkGeneric 11/2013 - 07/2012
2	Nuclear Proteins (Protein, Nuclear)IBA 07/2013 - 08/2012
2	PolyubiquitinIBA 03/2011 - 04/2010
1	Lenalidomide (CC 5013)FDA Link 04/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 04/2022
1	Bortezomib (Velcade)FDA Link 04/2022
1	NAD (NADH)IBA 01/2022
1	CarbonIBA 01/2022
1	Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA 01/2022
1	CytokinesIBA 01/2022
1	diazonaphthalenedisulfonic acid (NDS)IBA 01/2022
1	LipofuscinIBA 01/2022
1	Sirtuin 2IBA 01/2022
1	MetalsIBA 01/2022
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2022
1	OsteoprotegerinIBA 01/2022
1	Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric 01/2022
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 06/2021
1	Mitogen-Activated Protein KinasesIBA 06/2021
1	Epoxide HydrolasesIBA 01/2021
1	SteroidsIBA 01/2021
1	Bile Acids and Salts (Bile Acids)IBA 01/2021
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2021
1	EndocannabinoidsIBA 01/2021
1	Heme (Haem)IBA 01/2021
1	OxylipinsIBA 01/2021
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2021
1	SynucleinsIBA 12/2020
1	microtubule-associated protein 1B (MAP5)IBA 01/2020
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2020
1	moesinIBA 01/2020
1	SugarsIBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	alpha-SynucleinIBA 01/2020
1	ELAV-Like Protein 2IBA 01/2020
1	CholesterolIBA 01/2019
1	ApolipoproteinsIBA 01/2018
1	DipeptidesIBA 01/2018
1	LipopolysaccharidesIBA 01/2017
1	Blood Proteins (Serum Proteins)IBA 01/2017
1	TrypsinIBA 01/2017
1	Poly(A)-Binding Protein IIIBA 01/2017
1	OsteopontinIBA 01/2017
1	polyalanineIBA 01/2017
1	sarkosylIBA 12/2016

Therapy/Procedure

3	Therapeutics 04/2022 - 08/2015
1	Radiotherapy 01/2019